SYNBIO BIZ. “In 2010, U.S. revenues from genetically modified systems reached over $300 billion, or > 2% of GDP: genetically modified drugs (i.e., “biologics”) at $75 billion; genetically modified seeds and crops at $110 billion; and industrial biotechnology (e.g., fuels, materials, and enzymes) at $115 billion; China and Malaysia may each have biotech revenues in excess of 2.5% of GDP, and both plan to double by 2020.””
”
http://lnkd.in/cFaBdc.
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022